MTI013

Product Specifications

Target

Opioid Receptor|||SARS-CoV

Related Pathways

GPCR/G Protein|||Endocrinology/Hormones|||Neuroscience|||Microbiology/Virology

Bioactivity

MTI013 is a selective inhibitor of SARS-CoV-2 nsp14 Mtase (IC50: 2.98 µM) and an antiviral agent (IC50: 10.33 µM in HCoV-229E infected Huh7 cells) . Additionally, MTI013 demonstrates synergistic antiviral effects when used in conjunction with the RdRp inhibitor SHEN26.

Smiles

O=C(C1=CC(CSC[C@H]2[C@H](O)[C@@H](O)[C@H](N3C(N=CN=C4N)C4N=C3)O2)=CC=C1)NC5=CC=CC=C5

Molecular Formula

C24H26N6O4S

Molecular Weight

494.57

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

FAB5387D 0.1 mL

Mouse Monoclonal PEDFR/PNPLA2/ATGL Antibody (494702) [DyLight 350]

Ask

View Details

RC215498L4 10 µg

MOGAT3 (NM_178176) Human Tagged Lenti ORF Clone

Ask

View Details

MR200404L3V 200 µL

1700034O15Rik (Llcfc1) (NM_029671) Mouse Tagged ORF Clone Lentiviral Particle

Ask

View Details